MedTrace Logo

Leadership for Recovery: Evaluation of an Intervention Programme for First-line Healthcare Managers

NCT06678347 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 960

Last updated 2024-11-18

No results posted yet for this study

Summary

The goal of this intervention study is to evaluate a group intervention programme that aims to support first-line healthcare managers in promoting their employees' recovery through a "leadership for recovery".

In the study, the researchers will investigate if the intervention programme can improve the recovery (including sleep) of healthcare employees. The intervention programme consists of 6 group sessions for managers.

The main question the study aims to answer are:

\- Can a group-based intervention programme with a focus on strengthening first-line healthcare managers' leadership for recovery improve their employees' recovery?

The intervention programme will be delivered to first-line healthcare managers in Swedish hospital care settings. Researchers will compare survey, diary and actigraphy data between employees of 1) managers who participate in the programme and 2) managers who has not participated in the programme.

Conditions

  • Recovery, Psychological
  • Sleep
  • Burnout
  • Work Related Stress
  • Insomnia
  • Fatigue

Interventions

BEHAVIORAL

Leadership for recovery

The intervention will be delivered as a group-based programme (6 sessions) to the managers of the included employees. The programme includes educative and reflective parts as well as various strategies promoting both managers' own recovery and the recovery of employees.

Sponsors & Collaborators

Principal Investigators

  • Anna Dahlgren, Docent · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-13
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06678347 on ClinicalTrials.gov